Moleculin Biotech
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $29,631,000.
Profit Margin
| 2015 | 0 | -748.36K | |
|---|---|---|---|
| 2016 | 0 | -3.92M | |
| 2017 | 0 | -9.80M | |
| 2018 | 0 | -11.87M | |
| 2019 | 0 | -13.20M | |
| 2020 | 0 | -14.99M | |
| 2021 | 0 | -8.86M | |
| 2022 | 0 | -27.41M | |
| 2023 | 0 | -29.76M |
MBRX Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 127K | 222K | 260K | 285K | 185K | 0 | 18K | 0 | 0 |
Gross profit | -127K | -222K | -260K | -285K | -185K | 0 | -18K | 0 | 0 |
Operating exp. | |||||||||
Research and development | 19.48M | 18.96M | 14.41M | 12.75M | 11.01M | 9.72M | 4.54M | 1.49M | 260.41K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -668.93K |
Total operating expenses | 29.63M | 30.64M | 22.96M | 19.74M | 17.52M | 15.02M | 8.65M | 3.88M | 738.22K |
Operating income | -29.63M | -30.64M | -22.96M | -19.74M | -17.52M | -15.02M | -8.65M | -3.88M | -738.23K |
Other income (expenses), net | -138K | 1.61M | 7.07M | 2.38M | 4.09M | 3.14M | -1.15M | -43.21K | -10.13K |
Income before tax | -29.76M | -29.02M | -15.89M | -17.35M | -13.43M | -11.87M | -9.80M | -3.92M | -748.36K |
Income tax expense | 0 | -1.61M | -7.03M | -2.35M | -229K | 3.14M | 1.15M | 0 | -1.77M |
Net income | -29.76M | -27.41M | -8.86M | -14.99M | -13.20M | -11.87M | -9.80M | -3.92M | -748.36K |
Earnings per share | |||||||||
Basic EPS | -15.07 | -14.37 | -4.94 | -22.85 | -29.18 | -2.75 | -47.52 | -2.4 | -11.88 |
Diluted EPS | -15.07 | -14.37 | -4.94 | -22.85 | -29.18 | -2.75 | -47.52 | -2.4 | -11.83 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |